Literature DB >> 16998776

Efforts at rubella elimination in the United States: the impact of hemispheric rubella control.

Gustavo H Dayan1, Carlos Castillo-Solórzano, Margarita Nava, Bradley S Hersh, Jon Andrus, Romeo Rodriguez, Susan E Reef.   

Abstract

We examined rubella vaccination trends, rubella surveillance, and disease patterns for the Americas, Mexico, and the United States, to evaluate the impact of hemispheric rubella control on rubella elimination in the United States during 1997-2004. In 1997, 130,375 rubella cases were reported in the Americas, with 38,042 reported in Mexico. Over the next 7 years, a rubella control initiative resulted in the administration of approximately 110 million rubella-containing vaccine doses in Latin America, with 77.7 million doses administered within Mexico. By 2004, the number of reported rubella cases had declined to 3103 in the Americas and 698 in Mexico. Concurrently, the number of rubella cases in the United States fell from 817 during 1997-1999 to <25 cases/year from 2001 onward, with loss of seasonality and geographic clustering, despite no change in vaccination rates. Implementation of rubella control strategies in the Americas, particularly in Mexico, appears to have facilitated rubella elimination in the United States.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998776     DOI: 10.1086/505949

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Congenital rubella syndrome: the end is in sight.

Authors:  Scott R Lambert
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

2.  Surveillance and control of rubella in the republic of Korea from 2001 to 2009: the necessity for enhanced surveillance to monitor congenital rubella syndrome.

Authors:  Young June Choe; Sang Taek Lee; Kyung Min Song; Heeyeon Cho; Geun-Ryang Bae; Jong-Koo Lee
Journal:  Osong Public Health Res Perspect       Date:  2010-12-07

3.  Seroprevalence of rubella IgG antibody in pregnant women in osogbo, Nigeria.

Authors:  Olatunji Mathew Kolawole; Ekuntoye O Anjorin; Daniel A Adekanle; Caroline Folashade Kolawole; Kabir Adekunle Durowade
Journal:  Int J Prev Med       Date:  2014-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.